相关实验视频

Updated: Sep 20, 2025

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

单不和脂肪酸的失调与多个系统缩中的α-Synuclein有关

Finula I Isik^1,2, YuHong Fu^1,2, Russell Pickford³

¹Brain and Mind Centre, The University of Sydney, Sydney, NSW, Australia.

Movement disorders : official journal of the Movement Disorder Society

|May 23, 2025

概括

多重系统缩 (MSA) 涉及特定大脑区域的脂肪酸水平异常,尽管酶活性降低. 这表明一种新的途径有助于MSA病原和α-synuclein病理.

科学领域:

神经退行性疾病的神经退行性疾病
生物化学生物化学
分子病理学分子病理学

背景情况:

多重系统缩 (MSA) 的特点是质细胞质缩 (GCI) 中的α-synuclein聚合物.
帕金森病中单不和脂肪酸 (MUFA) 的增加促进了α-synuclein毒性,而抑制stearoyl-CoA脱酶 (SCD) 则减轻了它.
脂MUFA和SCD在MSA中的作用在很大程度上是未知的.

研究的目的:

为了调查MSA脑组织中脂MUFA和SCD水平的变化.
确定MSA中MUFA,SCD和α-synuclein病理之间的关系.

主要方法:

在死后的MSA中分析脂MUFA,并控制大脑运动皮质白质 (MWM) 和上皮质 (SOC),使用液态染色体质谱法.
通过免疫光检测,西部斑点检测和qPCR评估GCI,α-synuclein和SCD.
使用ELISA对血清SCD的量化.

主要成果:

在MSA MWM中观察到高的MUFA水平 (酸,酸胆,酸乙醇胺),但不是SOC.
在MSAMWM中,MUFA与α-synuclein有很强的相关性.
仅在MSA MWM中发现了SCD mRNA和蛋白质表达的降低.

结论:

MUFA的失调在特定的MSA大脑区域普遍存在,尽管SCD表达减少,但水平仍然很高.
这项研究揭示了MSA病变发生过程中以前未知的途径.
这些发现为MSA研究和理解其分子机制开辟了新的途径.

关键词:

单不和脂肪酸单不和脂肪酸单不和脂肪酸多个系统缩.脂酸是一种脂酸.乙醇-CoA脱酸酶的使用情况 α-synuclein 是一种同核蛋白.

更多相关视频

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

Technique for Intranasal Administration of α-Synuclein Aggregates

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

相关概念视频

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...